Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Serum-free medium suitable for culturing gamma delta T cells

A serum-free medium and basal medium technology, applied in animal cells, vertebrate cells, blood/immune system cells, etc., can solve the problems of different serum origins, batch numbers, influence on cell growth, and high price, so as to avoid inconvenience. Determining effect, good killing effect, effect of increasing final density

Inactive Publication Date: 2014-06-04
SHANGHAI CLAISON BIOTECH
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, since animal serum contains animal ingredients, if it is used in a clinical cell therapy system, it may cause some potential risks. This is mainly due to the complex composition of animal serum. Although it contains many beneficial ingredients for cells, there are also many unfavorable cells. Growth factors exist: 1) Animal serum contains some substances that are toxic to cells, such as polyamine oxidase, which can react with polyamines from highly reproductive cells (such as spermine, spermidine) to form cytotoxic polyamines. Spermine, complement, antibodies, bacterial toxins, etc. will all affect cell growth and even cause cell death; 2) Individual animals are different, and serum origin and batch numbers are different, and the quality of each batch varies greatly, and its components cannot be kept consistent; 3) The samples may contain Mycoplasma and viruses may have potential effects on cells, which may lead to experimental failure or unreliable experimental results; 4) In large-scale production, the source of serum is becoming more and more difficult and expensive, which constitutes the main part of the production cost of animal cell culture one

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Serum-free medium suitable for culturing gamma delta T cells
  • Serum-free medium suitable for culturing gamma delta T cells
  • Serum-free medium suitable for culturing gamma delta T cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1 Preparation of serum-free medium suitable for culturing γδT cells

[0032] Prepare 100L of culture medium, calculated according to Table 3, see Table 4 for the quality of each component required to prepare 100L of γδT cell serum-free culture medium.

[0033] Table 4

[0034]

[0035]

[0036] The preparation method is:

[0037] (1) Take the raw materials of component I, mix them evenly, dry them under vacuum at 60°C for 15 hours, and set aside; take the raw materials of component II, dry them under vacuum at 30°C for 18 hours, mix them well, and set them aside;

[0038] (2) Mix the above dried components I and II, pin mill for 3 hours, and pass through a 30-mesh sieve to obtain a solid powder. The temperature in the production process is controlled at 20-25°C, and the humidity is controlled at 15-20%. The nitrogen pressure was controlled at 150-300 psi; water was added to the solid powder, mixed evenly, and filtered through a 0.2 μm filter membrane to ...

Embodiment 2

[0039] Example 2 Using γδT cell serum-free medium to cultivate γδT cells and comparing the culture effect with the culture medium of the control group

[0040] Proceed as follows:

[0041] (1) Machine mining at least 1×10 9 Mononuclear cells (PBMC) of patients (blood cell separator model COM.TEC, manufacturer Fresenius Kabi, set the program to autoMNC in Leukocyte-Aphersis);

[0042] (2) Transfer the collected blood sample into a 50ml centrifuge tube, centrifuge at 400g for 10min; take the supernatant plasma and freeze it, and dilute the remaining blood with PBS;

[0043] (3) Slowly add 30ml of diluted blood to 15ml of Ficoll-Hypaque, set the deceleration process to brake off, and then centrifuge at 900g for 20min;

[0044] (4) After centrifugation, gently insert a flat-mouth Pasteur pipette into the mononuclear cell layer, carefully and accurately draw the layer of cells along the tube wall and transfer to another new 50ml centrifuge tube, add physiological 50ml of saline,...

Embodiment 3

[0050] Example 3 γδT Cell Flow Cytometry Detection

[0051] Proceed as follows:

[0052] (1) will contain approximately 1x10 6 Add the cell suspension to be tested into the corresponding numbered flow tube, 1500rpm, 5min, discard the supernatant;

[0053] (2) Add 2mL flow staining buffer, resuspend the cells, 1500rpm, 5min, discard the supernatant;

[0054] (3) Add 300 μL of flow staining buffer, resuspend the cells, and divide them into three parts. One part is set as a negative control (no antibody), and the other two tubes are added with fluorescently labeled monoclonal antibodies (note that the corresponding quantity);

[0055] (4) Incubate at room temperature in the dark for 30 minutes; add 1 mL flow staining buffer, 1500 rpm, 5 minutes, discard the supernatant; repeat washing once;

[0056] (5) Resuspend the cells with 300 μL flow staining buffer and wait for analysis.

[0057] Results: The γδT cells obtained on the 15th day of culture in two different media were de...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a serum-free medium suitable for culturing gamma delta T cells. The serum-free medium consists of a basal culture medium component I, a gamma delta T cell specific culture component II and water. Experiments show that by adopting the serum-free medium suitable for culturing the gamma delta T cells, the gamma delta T cells obtained is greater in quantity, higher in purity and better in killing effect. The serum-free medium suitable disclosed by the invention has the advantages that 1) the risk of animal components which are used in animal serums in the cell culture with the gamma delta T cells on patients with cell therapy and uncertain impact of uncertain components in the animal serums on the result of the cell culture are avoided; 2) the yield of the gamma delta T cells is greatly improved; and 3) the final density of the gamma delta T cell culture is increased so as to lower the cost of cell culture.

Description

technical field [0001] The invention relates to a serum-free medium suitable for culturing γδT cells. Background technique [0002] γδT cells were discovered in the mid-1980s. There are two main subtypes: Vγ9 / Vδ2 and Vδ1. γδT only accounts for 0.5% to 5% of peripheral blood T lymphocytes, of which more than 90% are Vγ9 / Vδ2 cells . Vδ1 is mainly distributed in epithelial tissues, such as intestine, spleen, skin, small intestine, esophagus, lung and reproductive organs. [0003] γδT cells have the characteristic of rapid response in vivo. When stimulated, it will release pro-inflammatory cytokines before αβ-T cells, such as IFN-γ and TNF-α; it has high lethality to tumor cells, and can recognize MICA / B on the surface of tumor cells through the cell membrane surface molecule NKG2D and DNAM-1 and other membrane proteins to initiate a variety of ways to kill tumor cells, such as the release of perforin, granzyme, FasL, Trail, etc.; γδT cells can also activate the tumor cytotox...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0783
Inventor 叶永清
Owner SHANGHAI CLAISON BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products